TY - JOUR
T1 - CT of the extrahepatic bile ducts
T2 - Wall thickness and contrast enhancement in normal and abnormal ducts
AU - Schulte, S. J.
AU - Baron, R. L.
AU - Teefey, S. A.
AU - Rohrmann, C. A.
AU - Freeny, P. C.
AU - Shuman, W. P.
AU - Foster, M. A.
PY - 1990/1/1
Y1 - 1990/1/1
N2 - Recent reports have described thickening and enhancement of the extrahepatic bile duct wall on CT scans obtained after administration of IV contrast material. We undertook this study to establish parameters for the normal thickness and enhancement of the bile duct wall on CT, and to develop a differential diagnosis for thickening of the duct wall. Routine CT examinations of 100 patients without biliary disease were evaluated prospectively. The common hepatic duct and common bile duct could be visualized in 66% and 82% of cases, respectively; the walls of these ducts could be separately discerned in 59% and 52%. The mean thickness of the duct wall was 1 mm, with a maximal thickness of 1.5 mm. Wall enhancement was similar to (51%), slightly greater than (44%), or markedly greater than (5%) the enhancement of adjacent pancreatic parenchyma. A review of records covering a 5-year period identified 52 patients in whom CT showed thickening of the bile duct wall (≥2 mm). These patients could be categorized by seven underlying diseases, and analysis of the CT scans revealed four general patterns of thickening. Focal, concentric wall thickening in the distal common bile duct was associated with pancreatitis, pancreatic cancer, and common bile duct stones; focal, eccentric thickening tended to occur with cholangiocarcinoma and sclerosing cholangitis. Diffuse, concentric thickening was seen with acute cholangitis; diffuse, eccentric thickening was associated with oriental cholangiohepatitis and sclerosing cholangitis. Thickening of greater than 5 mm was seen only with cholangiocarcinoma. Enhancement of the duct wall in these groups varied and was of no predictive value. In summary, the extrahepatic bile ducts can be visualized in the majority of patients, and the normal duct wall should be 1.5 mm or less in thickness. Contrast enhancement of the duct wall occurs in patients without biliary tract disease and alone is not predictive of pathology. Pancreatitis, pancreatic cancer, common bile duct stones, cholangiocarcinoma, sclerosing cholangitis, acute cholangitis, and oriental cholangiohepatitis are associated with thickening of the duct wall.
AB - Recent reports have described thickening and enhancement of the extrahepatic bile duct wall on CT scans obtained after administration of IV contrast material. We undertook this study to establish parameters for the normal thickness and enhancement of the bile duct wall on CT, and to develop a differential diagnosis for thickening of the duct wall. Routine CT examinations of 100 patients without biliary disease were evaluated prospectively. The common hepatic duct and common bile duct could be visualized in 66% and 82% of cases, respectively; the walls of these ducts could be separately discerned in 59% and 52%. The mean thickness of the duct wall was 1 mm, with a maximal thickness of 1.5 mm. Wall enhancement was similar to (51%), slightly greater than (44%), or markedly greater than (5%) the enhancement of adjacent pancreatic parenchyma. A review of records covering a 5-year period identified 52 patients in whom CT showed thickening of the bile duct wall (≥2 mm). These patients could be categorized by seven underlying diseases, and analysis of the CT scans revealed four general patterns of thickening. Focal, concentric wall thickening in the distal common bile duct was associated with pancreatitis, pancreatic cancer, and common bile duct stones; focal, eccentric thickening tended to occur with cholangiocarcinoma and sclerosing cholangitis. Diffuse, concentric thickening was seen with acute cholangitis; diffuse, eccentric thickening was associated with oriental cholangiohepatitis and sclerosing cholangitis. Thickening of greater than 5 mm was seen only with cholangiocarcinoma. Enhancement of the duct wall in these groups varied and was of no predictive value. In summary, the extrahepatic bile ducts can be visualized in the majority of patients, and the normal duct wall should be 1.5 mm or less in thickness. Contrast enhancement of the duct wall occurs in patients without biliary tract disease and alone is not predictive of pathology. Pancreatitis, pancreatic cancer, common bile duct stones, cholangiocarcinoma, sclerosing cholangitis, acute cholangitis, and oriental cholangiohepatitis are associated with thickening of the duct wall.
UR - http://www.scopus.com/inward/record.url?scp=0025139504&partnerID=8YFLogxK
U2 - 10.2214/ajr.154.1.2104731
DO - 10.2214/ajr.154.1.2104731
M3 - Article
C2 - 2104731
AN - SCOPUS:0025139504
SN - 0361-803X
VL - 154
SP - 79
EP - 85
JO - American Journal of Roentgenology
JF - American Journal of Roentgenology
IS - 1
ER -